7Baggers

We provide you with 20 years of free, institutional-grade data for ALBO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ALBO. Explore the full financial landscape of ALBO stock.

Reported DateCIKTickerType
2022-11-081322505ALBO10-QUrl
2022-08-151322505ALBO10-QUrl
2022-05-161322505ALBO10-QUrl
2022-03-011322505ALBO10-KUrl
2021-11-041322505ALBO10-QUrl
2021-08-051322505ALBO10-QUrl
2021-05-061322505ALBO10-QUrl
2021-02-251322505ALBO10-KUrl
2020-11-051322505ALBO10-QUrl
2020-08-061322505ALBO10-QUrl
2020-05-071322505ALBO10-QUrl
2020-03-021322505ALBO10-KUrl
2019-11-061322505ALBO10-QUrl
2019-08-081322505ALBO10-QUrl
2019-05-091322505ALBO10-QUrl
2019-03-061322505ALBO10-KUrl
2018-11-081322505ALBO10-QUrl
2018-08-091322505ALBO10-QUrl
2018-05-101322505ALBO10-QUrl
2018-03-271322505ALBO10-KUrl
2017-11-141322505ALBO10-QUrl
2017-08-211322505ALBO10-QUrl
2017-05-111322505ALBO10-QUrl
2017-03-271322505ALBO10-KUrl
2016-12-221322505ALBO10-KUrl
2016-08-111322505ALBO10-QUrl
2016-05-101322505ALBO10-QUrl
2016-02-161322505ALBO10-QUrl
2015-12-221322505ALBO10-KUrl
2015-08-141322505ALBO10-QUrl
2015-05-071322505ALBO10-QUrl
2015-03-191322505ALBOS-1Url
2015-02-121322505ALBO10-QUrl
2014-12-191322505ALBO10-KUrl
2014-08-141322505ALBOS-1Url
2014-08-131322505ALBO10-QUrl
2014-05-141322505ALBO10-QUrl
2014-02-101322505ALBO10-QUrl
2013-12-201322505ALBO10-KUrl
2013-08-141322505ALBO10-QUrl
2013-05-131322505ALBO10-QUrl
2013-02-141322505ALBO10-QUrl
2012-12-211322505ALBO10-KUrl
2012-08-141322505ALBO10-QUrl
2012-05-151322505ALBO10-QUrl
2012-02-091322505ALBO10-QUrl
2011-12-151322505ALBO10-KUrl
2011-08-091322505ALBO10-QUrl
2011-05-091322505ALBO10-QUrl
2011-02-071322505ALBO10-QUrl
2010-12-141322505ALBO10-KUrl
2010-08-061322505ALBO10-QUrl
2010-05-071322505ALBO10-QUrl
2010-02-051322505ALBO10-QUrl
2009-12-141322505ALBO10-KUrl
2009-08-071322505ALBO10-QUrl
2009-05-081322505ALBO10-QUrl
2009-02-061322505ALBO10-QUrl
2008-12-111322505ALBO10-KUrl
2008-08-111322505ALBO10-QUrl
2008-05-091322505ALBO10-QUrl
2008-02-141322505ALBO10-QUrl
2008-01-161322505ALBOS-1Url
2007-12-211322505ALBO10-KUrl
2007-08-011322505ALBO10-QUrl
2007-06-151322505ALBO10-QUrl
2007-02-071322505ALBOS-1Url

Albireo Pharma, Inc
(NASDAQ:ALBO) 

ALBO stock logo

Albireo Pharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. Its lead product candidate is odevixibat, an ileal bile acid transpor...

Full Time Employees: 90 (May 2021)
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
The information provided in this report about ALBO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.